The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CCEL · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CCEL | CLDX | AXGN | EOLS |
|---|---|---|---|---|
| Moat Score (0–100) | 42 (highest) | 42 (highest) | 42 (highest) | 42 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 44 | 15 | 60 | 65 (highest) |
| Pricing power | 99 (highest) | 95 | 98 | 92 |
| Returns on capital | — | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 0 | 55 (highest) | 28 | 28 |
| Capital allocation | 24 | 44 (highest) | 24 | 24 |
| 524% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $27.9M | $2.3B | $1.9B | $389M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |